Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4

Sponsor Class

NIH 7NETWORK 4OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3Dermatologic 1

Conditions

Breast Neoplasms 3Carcinoma, Merkel Cell 1

Interventions

Radiotherapy 214Cisplatin 180Cyclophosphamide 169Doxorubicin 138Vincristine 127Paclitaxel 125Filgrastim 121Etoposide 104Carboplatin 100Methotrexate 83Gemcitabine 82Docetaxel 78Cytarabine 78Gene Expression Profiling 74Fluorouracil 74Prednisone 71Granulocyte Colony-Stimulating Factor 66Dexamethasone 66Leucovorin 62Polymerase Chain Reaction 47Immunohistochemistry 46Microarray Analysis 40Daunorubicin 38Irinotecan 37Ifosfamide 37Temozolomide 35Cetuximab 33Amplified Fragment Length Polymorphism Analysis 33Peripheral Blood Stem Cell Transplantation 32Mercaptopurine 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × NETWORK × CMF regimen × Clear all
NCT00036868 2024-03-08

Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
90 enrolled
Breast

Breast Neoplasms

NCT00002542 2020-04-01

Tamoxifen in Treating Women With High-Risk Breast Cancer

Canadian Cancer Trials Group

Phase 3 Completed
672 enrolled
Breast

Breast Neoplasms

NCT00002784 2013-04-04

15-95

ETOP IBCSG Partners Foundation

Phase 3 Completed
344 enrolled
Breast

Breast Neoplasms

NCT00003549 2012-10-08

S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer

SWOG Cancer Research Network

Phase 2 Completed
80 enrolled
Dermatologic

Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡